- Consumer Products
- Latest 7.63
- Currency US$
- Change -0.01
- Percent Change -0.131 %
- Volume 1,716,673
- Tue Sep 23, 2014 02:08 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Aug 11||$0.55||Nov 5||$0.71|
|Dividends||Sep 3||$0.15||Dec 3||$0.15|
12 months ended Sep 23, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Head Office932 SOUTHWOOD BLVD